Total Funding
60
40
Total FundingGrant raised
Growth Score 60 in past quarter
-6 pts
Heat Score 40 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
46066
Promise Bio utilizes AI to analyze epiproteomics for autoimmune diseases.
- Yifat Merbl: Scientific Co-Founder
- Ronel Veksler: Co-Founder & CEO
About the Company
Promise Bio is focused on pioneering precision medicine by utilizing epiproteomic analysis to understand autoimmune diseases. The company employs a cloud-based AI platform to perform comprehensive analyses of standard mass-spectrometry data, revealing insights into protein modifications that affect disease mechanisms.
